Ethics of Offshoring: Novo Nordisk and Clinical Trials in Emerging Economies Harvard Case Solution & Analysis

The case presents conflicting ethical demands on the Danish pharmaceutical company Novo Nordisk, which operates throughout the world and is committed to high standards of corporate social responsibility. A recent report states that multinational pharmaceutical companies regularly conduct research in developing countries as part of the alleged unethical conditions. Director of thinking about how to respond to a request for an interview with a journalist. This is the discussion of the relevant ethical principles and how to report them. As a company, emphasizing corporate responsibility, interaction with the media presents both opportunities and risks for the company Novo Nordisk. The case focuses on the clinical trials that are necessary to achieve regulatory approval, for example, in Europe and North America, and are conducted at multiple sites around the world, including many of the emerging economies. Novo Nordisk has implemented a number of procedures to protect its various stakeholders, but it will meet journalists and non-governmental organizations, and how a company should deal with these stakeholders? "Hide
by Klaus Meyer Source: Richard Ivey School of Business Foundation 13 pages. Publication Date: 09 January 2009. Prod. #: 909M01-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.